Drug delivery routes and challenges play a significant role in determining the effectiveness of pharmaceutical treatments. Different routes, such as oral, intravenous, transdermal, and inhalational, offer unique benefits but also come with specific obstacles. Oral delivery is widely used for its convenience but is often hindered by issues like poor bioavailability and first-pass metabolism. Intravenous routes provide rapid action, though they require professional administration and carry infection risks. Transdermal delivery offers controlled, long-term release but faces limitations related to skin permeability. Inhalational routes are effective for targeting the lungs but present challenges in dosing accuracy and formulation stability. Each of these Drug Delivery Routes and Challenges requires innovative solutions to improve drug efficacy, safety, and patient adherence, with advances in targeted and nanotechnology-based drug delivery systems helping to overcome many of these barriers.
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Rational optimization of antibody–cyanine bioconjugates for targeted theranostic drug delivery and photo/sono activation
Amartya Sanyal, Ariel University, Israel
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : From in silico design to xenograft validation: Synthesis and evaluation of an Anti-EGFR antibody-derived peptide-drug conjugate for NSCLC
Pousali Mitra, Ariel University, Israel